IMGN logo

ImmunoGen (IMGN) Revenue

Annual Revenue

$108.78 M
+$38.93 M+55.72%

December 31, 2022

Summary

Performance

1-Year Change

+55.72%

3-Year Change

+32.22%

5-Year Change

-5.77%

15-Year Change

-5.77%

IMGN Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$377.85 M
IMGN annual revenue is currently -71.21% lower than the consensus analysts' forecast

High & Low

All-time High

$132.30 M
IMGN annual revenue is currently -17.78% below its historical high of $132.30 million

3-Year Low

$69.86 M
IMGN annual revenue is currently +55.72% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
IMGN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
IMGN next annual earnings announcement has not yet been scheduled

OtherIMGNprofitabilitymetrics:

Annual EPS

-$0.88
IMGN annual earnings per share is -$0.88

Annual Net Income

-$222.93 M
IMGN annual net profit is -$222.93 million

Annual Operating Profit

-$220.89 M
IMGN annual operating income is -$220.89 million

Annual Gross Profit

$108.61 M
IMGN annual gross profit is $108.61 million

Quarterly Revenue

$113.42 M
+$30.27 M+36.41%

September 30, 2023

Summary

Performance

3-Month Change

+36.41%

1-Year Change

+637.72%

3-Year Change

+523.59%

5-Year Change

+937.93%

IMGN Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$131.56 M
IMGN quarterly revenue is currently -13.78% lower than the consensus analysts' forecast

High & Low

All-time High

$113.42 M
IMGN quarterly revenue is currently at an all-time high

3-Year Low

$14.16 M
IMGN quarterly revenue is currently +700.91% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$111.27 M
IMGN quarterly gross profit is $111.27 million

Quarterly Operating Profit

$25.96 M
IMGN quarterly operating income is $25.96 million

Quarterly Net Income

$30.75 M
IMGN quarterly net profit is $30.75 million

Quarterly EPS

$0.10
IMGN quarterly earnings per share is $0.10

TTM Revenue

$287.61 M
+$98.05 M+51.72%

September 30, 2023

Summary

Performance

3-Month Change

+51.72%

1-Year Change

+200.83%

3-Year Change

+214.8%

5-Year Change

+249.59%

IMGN TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Analysts Estimate

$378.01 M
IMGN TTM revenue is currently -23.91% lower than the consensus analysts' forecast

High & Low

All-time High

$287.61 M
IMGN TTM revenue is currently at an all-time high

3-Year Low

$69.86 M
IMGN TTM revenue is currently +311.72% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNprofitabilitymetrics:

TTM Gross Profit

$283.75 M
IMGN TTM gross profit is $283.75 million

TTM Operating Profit

-$80.19 M
IMGN TTM operating income is -$80.19 million

TTM Net Income

-$73.52 M
IMGN TTM net profit is -$73.52 million

TTM EPS

-$0.31
IMGN TTM earnings per share is -$0.31

IMGN Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.7%+637.7%+200.8%
3 y3 years+32.2%+523.6%+214.8%
5 y5 years-5.8%+937.9%+249.6%

IMGN Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-35.8%at high-87.5%at high-75.7%
5 y5-year-17.8%-35.8%at high-91.9%at high-75.7%
alltimeall time-17.8%-99.5%at high-100.0%at high-100.0%

ImmunoGen Revenue History

DateAnnualQuarterlyTTM
Sep 2023
-
$113.42 M(+36.4%)
$287.61 M(+51.7%)
Jun 2023
-
$83.15 M(+66.7%)
$189.56 M(+57.2%)
Mar 2023
-
$49.87 M(+21.1%)
$120.57 M(+10.8%)
Dec 2022
$108.78 M(+55.7%)
$41.17 M(+167.8%)
$108.78 M(+13.8%)
Sep 2022
-
$15.38 M(+8.6%)
$95.61 M(+6.9%)
Jun 2022
-
$14.16 M(-62.8%)
$89.44 M(-3.0%)
Mar 2022
-
$38.08 M(+36.0%)
$92.23 M(+32.0%)
Dec 2021
$69.86 M(-47.2%)
$27.99 M(+203.9%)
$69.86 M(-45.3%)
Sep 2021
-
$9.21 M(-45.7%)
$127.66 M(-6.6%)
Jun 2021
-
$16.95 M(+7.9%)
$136.64 M(+1.4%)
Mar 2021
-
$15.71 M(-81.7%)
$134.72 M(+1.8%)
Dec 2020
$132.30 M(+60.8%)
$85.80 M(+371.7%)
$132.30 M(+44.8%)
Sep 2020
-
$18.19 M(+21.1%)
$91.36 M(+5.7%)
Jun 2020
-
$15.03 M(+13.1%)
$86.46 M(-0.6%)
Mar 2020
-
$13.29 M(-70.4%)
$86.97 M(+5.7%)
Dec 2019
$82.27 M(+53.9%)
$44.86 M(+237.8%)
$82.27 M(+61.9%)
Sep 2019
-
$13.28 M(-14.5%)
$50.82 M(+4.9%)
Jun 2019
-
$15.54 M(+81.1%)
$48.47 M(+14.8%)
Mar 2019
-
$8.58 M(-36.0%)
$42.22 M(-21.0%)
Dec 2018
$53.45 M(-53.7%)
$13.42 M(+22.8%)
$53.45 M(-32.8%)
Sep 2018
-
$10.93 M(+17.7%)
$79.48 M(+3.2%)
Jun 2018
-
$9.29 M(-53.1%)
$77.03 M(-27.8%)
Mar 2018
-
$19.82 M(-49.8%)
$106.76 M(-7.5%)
Dec 2017
$115.45 M(+436.8%)
$39.45 M(+365.2%)
$115.45 M(+51.9%)
Sep 2017
-
$8.48 M(-78.3%)
$76.00 M(+1.1%)
Jun 2017
-
$39.02 M(+36.9%)
$75.18 M(+72.6%)
Mar 2017
-
$28.50 M(+272.0%)
$43.57 M(-17.5%)
Dec 2016
$21.51 M(-64.2%)
-
-
Sep 2016
-
$7.66 M(+3.4%)
$52.81 M(-12.0%)
Jun 2016
$60.00 M(-29.9%)
$7.41 M(-62.4%)
$60.00 M(-8.0%)
Mar 2016
-
$19.71 M(+9.3%)
$65.20 M(+14.6%)
Dec 2015
-
$18.03 M(+21.4%)
$56.92 M(-34.7%)
Sep 2015
-
$14.85 M(+17.8%)
$87.19 M(+1.9%)
Jun 2015
$85.54 M(+42.8%)
$12.61 M(+10.4%)
$85.54 M(+8.7%)
Mar 2015
-
$11.43 M(-76.3%)
$78.67 M(+6.1%)
Dec 2014
-
$48.30 M(+265.8%)
$74.12 M(+32.6%)
Sep 2014
-
$13.20 M(+129.9%)
$55.88 M(-6.7%)
Jun 2014
$59.90 M(+68.6%)
$5.74 M(-16.5%)
$59.90 M(+3.3%)
Mar 2014
-
$6.88 M(-77.1%)
$57.98 M(-23.8%)
Dec 2013
-
$30.06 M(+74.6%)
$76.11 M(+56.4%)
Sep 2013
-
$17.22 M(+349.4%)
$48.66 M(+36.9%)
Jun 2013
$35.53 M(+117.2%)
$3.83 M(-84.7%)
$35.53 M(+2.5%)
Mar 2013
-
$25.00 M(+857.2%)
$34.66 M(+168.5%)
Dec 2012
-
$2.61 M(-36.2%)
$12.91 M(-27.9%)
Sep 2012
-
$4.09 M(+38.6%)
$17.91 M(+9.5%)
Jun 2012
$16.36 M(-15.3%)
$2.95 M(-9.2%)
$16.36 M(-17.8%)
Mar 2012
-
$3.25 M(-57.3%)
$19.91 M(-9.0%)
Dec 2011
-
$7.62 M(+200.4%)
$21.87 M(+18.7%)
Sep 2011
-
$2.54 M(-61.0%)
$18.43 M(-4.5%)
Jun 2011
$19.30 M(+38.5%)
$6.50 M(+24.8%)
$19.30 M(+12.1%)
Mar 2011
-
$5.21 M(+24.7%)
$17.22 M(+12.4%)
Dec 2010
-
$4.18 M(+22.5%)
$15.32 M(+7.5%)
Sep 2010
-
$3.41 M(-22.9%)
$14.26 M(+2.2%)
Jun 2010
$13.94 M(-50.2%)
$4.42 M(+33.4%)
$13.94 M(+0.9%)
Mar 2010
-
$3.31 M(+6.6%)
$13.82 M(-26.2%)
Dec 2009
-
$3.11 M(+0.3%)
$18.73 M(-24.9%)
Sep 2009
-
$3.10 M(-28.0%)
$24.96 M(-10.8%)
Jun 2009
$27.99 M(-30.5%)
$4.30 M(-47.7%)
$27.99 M(-0.6%)
Mar 2009
-
$8.23 M(-11.9%)
$28.17 M(-18.4%)
Dec 2008
-
$9.33 M(+52.4%)
$34.53 M(-1.2%)
Sep 2008
-
$6.13 M(+36.6%)
$34.95 M(-13.2%)
Jun 2008
$40.25 M(+5.3%)
$4.48 M(-69.3%)
$40.25 M(-9.1%)
Mar 2008
-
$14.59 M(+49.6%)
$44.30 M(+12.0%)
Dec 2007
-
$9.75 M(-14.7%)
$39.55 M(-5.5%)
Sep 2007
-
$11.43 M(+33.9%)
$41.87 M(+9.6%)
Jun 2007
$38.21 M(+19.1%)
$8.53 M(-13.2%)
$38.21 M(+0.4%)
Mar 2007
-
$9.84 M(-18.5%)
$38.05 M(+1.3%)
Dec 2006
-
$12.07 M(+55.4%)
$37.56 M(+17.1%)
Sep 2006
-
$7.77 M(-7.1%)
$32.08 M(-0.0%)
Jun 2006
$32.09 M
$8.37 M(-10.6%)
$32.09 M(+3.0%)
DateAnnualQuarterlyTTM
Mar 2006
-
$9.36 M(+42.0%)
$31.15 M(-2.7%)
Dec 2005
-
$6.59 M(-15.3%)
$32.03 M(-7.1%)
Sep 2005
-
$7.78 M(+4.6%)
$34.49 M(-3.4%)
Jun 2005
$35.72 M(+37.6%)
$7.43 M(-27.3%)
$35.72 M(-5.0%)
Mar 2005
-
$10.23 M(+13.1%)
$37.60 M(+7.6%)
Dec 2004
-
$9.05 M(+0.5%)
$34.95 M(+12.5%)
Sep 2004
-
$9.01 M(-3.3%)
$31.07 M(+19.7%)
Jun 2004
$25.96 M(+240.3%)
$9.31 M(+22.7%)
$25.96 M(+44.3%)
Mar 2004
-
$7.59 M(+47.0%)
$17.99 M(+51.7%)
Dec 2003
-
$5.16 M(+32.7%)
$11.86 M(+29.3%)
Sep 2003
-
$3.89 M(+188.4%)
$9.17 M(+20.2%)
Jun 2003
$7.63 M(+29.7%)
$1.35 M(-7.3%)
$7.63 M(-4.4%)
Mar 2003
-
$1.46 M(-41.2%)
$7.98 M(+3.2%)
Dec 2002
-
$2.48 M(+5.5%)
$7.74 M(+13.7%)
Sep 2002
-
$2.35 M(+37.8%)
$6.80 M(+15.6%)
Jun 2002
$5.88 M(+31.3%)
$1.70 M(+40.7%)
$5.88 M(+25.0%)
Mar 2002
-
$1.21 M(-21.6%)
$4.71 M(+4.1%)
Dec 2001
-
$1.54 M(+8.3%)
$4.52 M(+22.5%)
Sep 2001
-
$1.43 M(+171.8%)
$3.69 M(-17.6%)
Jun 2001
$4.48 M(-59.9%)
$524.70 K(-48.9%)
$4.48 M(-48.1%)
Mar 2001
-
$1.03 M(+43.6%)
$8.63 M(+13.5%)
Dec 2000
-
$714.80 K(-67.7%)
$7.60 M(-19.0%)
Sep 2000
-
$2.21 M(-52.7%)
$9.39 M(-16.0%)
Jun 2000
$11.18 M(+202.2%)
$4.68 M(>+9900.0%)
$11.18 M(+29.9%)
Mar 2000
-
$0.00(-100.0%)
$8.60 M(-11.3%)
Dec 1999
-
$2.50 M(-37.5%)
$9.70 M(+31.1%)
Sep 1999
-
$4.00 M(+90.5%)
$7.40 M(+105.6%)
Jun 1999
$3.70 M(+640.0%)
$2.10 M(+90.9%)
$3.60 M(+125.0%)
Mar 1999
-
$1.10 M(+450.0%)
$1.60 M(+128.6%)
Dec 1998
-
$200.00 K(0.0%)
$700.00 K(+16.7%)
Sep 1998
-
$200.00 K(+100.0%)
$600.00 K(+20.0%)
Jun 1998
$500.00 K(-16.7%)
$100.00 K(-50.0%)
$500.00 K(-28.6%)
Mar 1998
-
$200.00 K(+100.0%)
$700.00 K(+16.7%)
Dec 1997
-
$100.00 K(0.0%)
$600.00 K(0.0%)
Sep 1997
-
$100.00 K(-66.7%)
$600.00 K(0.0%)
Jun 1997
$600.00 K(0.0%)
$300.00 K(+200.0%)
$600.00 K(+20.0%)
Mar 1997
-
$100.00 K(0.0%)
$500.00 K(0.0%)
Dec 1996
-
$100.00 K(0.0%)
$500.00 K(0.0%)
Sep 1996
-
$100.00 K(-50.0%)
$500.00 K(-16.7%)
Jun 1996
$600.00 K(+20.0%)
$200.00 K(+100.0%)
$600.00 K(+20.0%)
Mar 1996
-
$100.00 K(0.0%)
$500.00 K(0.0%)
Dec 1995
-
$100.00 K(-50.0%)
$500.00 K(-16.7%)
Sep 1995
-
$200.00 K(+100.0%)
$600.00 K(0.0%)
Jun 1995
$500.00 K(-44.4%)
$100.00 K(0.0%)
$600.00 K(0.0%)
Mar 1995
-
$100.00 K(-50.0%)
$600.00 K(-14.3%)
Dec 1994
-
$200.00 K(0.0%)
$700.00 K(-12.5%)
Sep 1994
-
$200.00 K(+100.0%)
$800.00 K(-20.0%)
Jun 1994
$900.00 K(-47.1%)
$100.00 K(-50.0%)
$1.00 M(-16.7%)
Mar 1994
-
$200.00 K(-33.3%)
$1.20 M(-14.3%)
Dec 1993
-
$300.00 K(-25.0%)
$1.40 M(-12.5%)
Sep 1993
-
$400.00 K(+33.3%)
$1.60 M(-5.9%)
Jun 1993
$1.70 M(-37.0%)
$300.00 K(-25.0%)
$1.70 M(-19.0%)
Mar 1993
-
$400.00 K(-20.0%)
$2.10 M(-12.5%)
Dec 1992
-
$500.00 K(0.0%)
$2.40 M(-7.7%)
Sep 1992
-
$500.00 K(-28.6%)
$2.60 M(-3.7%)
Jun 1992
$2.70 M(-20.6%)
$700.00 K(0.0%)
$2.70 M(0.0%)
Mar 1992
-
$700.00 K(0.0%)
$2.70 M(+22.7%)
Dec 1991
-
$700.00 K(+16.7%)
$2.20 M(+29.4%)
Sep 1991
-
$600.00 K(-14.3%)
$1.70 M(-50.0%)
Jun 1991
$3.40 M(+240.0%)
$700.00 K(+250.0%)
$3.40 M(+13.3%)
Mar 1991
-
$200.00 K(0.0%)
$3.00 M(-3.2%)
Dec 1990
-
$200.00 K(-91.3%)
$3.10 M(-3.1%)
Sep 1990
-
$2.30 M(+666.7%)
$3.20 M(+220.0%)
Jun 1990
$1.00 M(+25.0%)
$300.00 K(0.0%)
$1.00 M(+11.1%)
Mar 1990
-
$300.00 K(0.0%)
$900.00 K(+12.5%)
Dec 1989
-
$300.00 K(+200.0%)
$800.00 K(0.0%)
Sep 1989
-
$100.00 K(-50.0%)
$800.00 K(0.0%)
Jun 1989
$800.00 K
$200.00 K(0.0%)
$800.00 K(+33.3%)
Mar 1989
-
$200.00 K(-33.3%)
$600.00 K(+50.0%)
Dec 1988
-
$300.00 K(+200.0%)
$400.00 K(+300.0%)
Sep 1988
-
$100.00 K
$100.00 K

FAQ

  • What is ImmunoGen annual revenue?
  • What is the all time high annual revenue for ImmunoGen?
  • What is ImmunoGen annual revenue year-on-year change?
  • What is ImmunoGen quarterly revenue?
  • What is the all time high quarterly revenue for ImmunoGen?
  • What is ImmunoGen quarterly revenue year-on-year change?
  • What is ImmunoGen TTM revenue?
  • What is the all time high TTM revenue for ImmunoGen?
  • What is ImmunoGen TTM revenue year-on-year change?

What is ImmunoGen annual revenue?

The current annual revenue of IMGN is $108.78 M

What is the all time high annual revenue for ImmunoGen?

ImmunoGen all-time high annual revenue is $132.30 M

What is ImmunoGen annual revenue year-on-year change?

Over the past year, IMGN annual revenue has changed by +$38.93 M (+55.72%)

What is ImmunoGen quarterly revenue?

The current quarterly revenue of IMGN is $113.42 M

What is the all time high quarterly revenue for ImmunoGen?

ImmunoGen all-time high quarterly revenue is $113.42 M

What is ImmunoGen quarterly revenue year-on-year change?

Over the past year, IMGN quarterly revenue has changed by +$98.05 M (+637.72%)

What is ImmunoGen TTM revenue?

The current TTM revenue of IMGN is $287.61 M

What is the all time high TTM revenue for ImmunoGen?

ImmunoGen all-time high TTM revenue is $287.61 M

What is ImmunoGen TTM revenue year-on-year change?

Over the past year, IMGN TTM revenue has changed by +$192.01 M (+200.83%)